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ABSTRACT  
 
Cardiac magnetic resonance (CMR) is a non-invasive imaging modality highly reliable 
for studying cardiovascular morphology and function. Cardiac computed tomography (CCT) 
can give valuable anatomic information on CHD in children but implies radiation exposure, a 
relevant issue in children and newborns who are more radiosensitive than adult patients and 
have a longer lifetime to develop stochastic effects from radiation. We contributed to show the 
possibility to obtain an impressively low ionizing dose reduction in CHD patients also using 
standard 64-slice CT scanners. Conversely, CMR holds a pivotal role when functional and flow 
imaging is required. We showed the role of CMR in evaluating of patients percutaneously 
implanted with a pulmonary valve. Moreover, we proposed two new approaches for post-
processing CMR images, regarding volume estimation of patients with a single ventricle, a rare 
CHD and a method for quantifying the paradoxical septal motion. CMR and CCT are two 
fundamental imaging techniques to evaluate patients with complex CHD. Both imaging 
modalities have limitations and advantages. CMR can evaluate heart function vessel flow but 
require a long acquisition time and in same patients a long sedation time. CCT has a very high 
spatial resolution and short acquisition time but implies ionizing radiation exposure. On the one 
side, we confirming the crucial role of CMR when function analysis is required but also showed 
the relevant possibilities of x-ray dose reduction in CCT, also using standard 64-slice scanners 
in the study of CHD patients. 
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1. Introduction 
1.1 Computed tomography: general overview 
Multislice computed tomography (CT) allows for obtaining important information about 
anatomical and functional conditions of the heart during a single examination session. Cardiac 
CT (CCT) images in the context of non-cardiac-targeted thoracic studies are degraded by 
motion artifacts due to cardiac pulsation. In fact, routine thoracic CT studies that are not 
synchronized to the patient’s ECG cycle. The synchronization of CT acquisition with the ECG 
allows obtaining images substantially free of motion artifacts. Non-contrast CCT scans 
synchronized to ECG for the end-diastolic phase allows the evaluation of calcium deposits in 
coronary atherosclerotic lesions. Notably, the CCT spatial resolution is higher than that of 
cardiac magnetic resonance (CMR), while CCT time resolution is lower than that of CMR. 
When a clinical balance between CCT and CMR has to be carried out, the ionizing radiation 
exposure of patients, in particular those in pediatric age, is an important issue to be 
considered. However, the recently reduction of ionizing radiation exposure with the last 
generation CT scanners opened a new scenario. 
 
1.2 Cardiac magnetic resonance: general overview 
CMR imaging is a technique highly reliable in evaluating the heart and related structures. It has 
a wide range of clinical applications: cardiomyopathies, coronary artery disease, heart failure, 
valvulopathies, congenital heart disease, and other non-ischemic alterations, such as primary 
cardiac tumors, cardiac metastases, and pericardial disease. Images of the heart are obtained 
along the most useful planes: the short axis, the horizontal long axis (also known as 4-
chamber view of the heart), and the vertical long axis. Different sequences allow the physician 
to focus on different features of the heart, evaluating cardiac morphology and/or function. 
Bright-blood images, where the flowing blood signal is high, are mainly used to evaluate 
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function, whereas the black-blood images, where the flowing blood signal is suppressed, are 
mainly used to assess heart morphology. To evaluate acute and chronic myocardial 
dysfunction, late gadolinium enhancement sequences allow the physician to identify and 
quantify focal fibrosis caused by ischemic heart disease, such as myocardial infarction, or by 
other non-ischemic conditions. 
  CMR is crucial for the evaluation of congenital heart diseases (CHD), defined as defects of 
the cardiac structure present at birth. In CHD, genetic and/or environmental causes may impair 
the heart’s development, and therefore its capability to properly provide deoxygenated blood to 
the lungs in the pulmonary artery, to receive oxygenated blood from the pulmonary veins, and 
to provide oxygenated blood to the aorta. CHD patients may also require much more frequent 
examinations than the general population from a very young age; an unregulated usage of 
CCT to evaluate their condition could have a great impact in terms of lifetime risk of cancer, as 
it will be addressed below.  CMR provides a completely radiation-free tool, allowing physicians 
to obtain information as regularly as they may deem useful, without having to worry about the 
risk of significantly increasing the likelihood of cancer in these patients. However, especially in 
very young pediatric patients, a risk associated with a prolonged sedation, sometimes 
necessary for performing CMR, should be considered. 
 
1.3 Cardiovascular imaging with CCT and CMR in CHD 
Incidence of CHD is 4 -14 per 1000 live births, the isolated ventricular septal defect being the 
most common [1,2]. Other simple CHD are patent ductus arteriosus, atrial septal defect of the 
fossa ovalis (ostium secundum), isolated partial anomalous pulmonary venous connection, 
aortic coarctation, and bicuspid aortic valve [3]. The main complex CHDs are Fallot tetralogy 
(incidence 0.4 per 1000 live births), transposition of great arteries, double-outlet right ventricle, 
truncus arteriosus, and single ventricle [4]. Echocardiography is the first approach for CHD. 
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However, it is limited by operator dependence, acoustic window restrictions, and inability to 
detect extracardiac abnormalities [5]. Catheterization for digital subtraction angiography (DSA) 
is the reference procedure for treatment planning [6]. Cardiac magnetic resonance (CMR) is a 
non-invasive imaging modality highly reliable for studying cardiovascular morphology and 
function. However, it is limited in children by long scan times, requirement for sedation and 
close monitoring [7]. CCT can give valuable anatomic information on CHD in children but 
implies radiation exposure, a relevant issue in children and newborns who are more 
radiosensitive than adult patients and have a longer lifetime to develop stochastic effects from 
radiation [8]. However, newer CCT technologies allow for an optimized combination of highly 
reduced radiation exposure, high spatial resolution, and very short examination time [9], 
making CT for CHD competitive with CMR. Papers regarding x-ray dose reduction in CCT as 
well as CCT and CMR in CHD are shown in the following pages. 
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2. Paper on cardiac computed tomography 
 2.1 The feasibility of low radiation dose acquisition in pediatric patient using a 64-
slice CT scanner (Under revision) 
 
Purpose 
The aim of this study was to evaluate the radiation dose and the image quality in pediatric 
cardiac CT angiography using a “standard” 64 slice scanner. 
Materials and Methods 
After institutional review board approval waived specific patient consent for data analysis, we 
retrospectively evaluated cardiac CT examinations performed in patients <18 years of age 
between the January 2010 and December 2014. CT examinations were performed on a 64-
slice CT scanner (Somatom 64, Siemens Healthcare, Forchheim, Germany). Patients less 
than 3 years old need sedation. A dedicated protocol was performed according to the clinical 
issue. In the majority of patients non-contrast scan was waived to reduce radiation dose.  A 
bolus of contrast agent from 5 to 60 mL (Iopamiro, Bracco) and saline water from 10 to 60 mL 
was injected intravenously at a flow rate from 1.5 to 3.0 ml/s according to patients 
characteristics. A test bolus injection technique was used. A time–enhancement curve was 
obtained by measuring the enhancement within the region of interest (ROI). The contrast 
agent arrival time was determined from the time to peak enhancement and was used to 
estimate scan delays for full-bolus diagnostic CT. This technique was used to study cardiac 
anatomy or coronary arteries. To acquire an angiogram we used the technique of bolus 
tracking, based on real-time monitoring of the main bolus during injection with the acquisition 
of a series of dynamic low-dose monitoring scans at the level of the vessel of interest. The 
trigger threshold inside the ROI was set at 100 HU above the baseline. The delay between 
each monitoring scan acquisition was 1.25 seconds. As soon as the threshold was reached, 
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the table moved to the cranial start position. During this interval the contrast material 
concentration increased to the desired level of enhancement. CT were performed using 
retrospective ECG-gating, prospective ECG-triggering, depending on the patient heart rate 
and rhythm and whether or not an evaluation of myocardial function was indicated or without 
ECG-gating. The reconstruction parameters were set as follows: the section thickness was 
0.75 mm, reconstruction interval 0.45 mm, matrix size 512 × 512, field of view (FOV) 250 mm. 
Those two-dimensional (2D) imaging sequences were then transferred to another computer 
for 3D anatomy reconstruction. In our department we adopted the policy that pediatric CT 
studies were to be performed under the supervision of a cardiovascular radiologist and 
instructed technicians to minimize technical errors. 
Estimation and Calculation of Effective Radiation Dose 
The volume computed tomography dose index (CTDIvol) was automatically provided by the 
system and tube current and dose length product (DLP) were retrieved for each patient.  
Effective radiation dose (ED) in millisieverts (mSv) was calculated as DLP*k (mSv/mGy/cm) 
for chest. The conversion factor, k, varied with age and was estimated from the International 
Commission on Radiological Protection (ICRP) publication 103 recommendation [46]. ED was 
then evaluated per patient age group (0–6 vs. 6–12 vs. 12–18 years), and tube potential (kV) 
used. 
Image Analysis  
For assessment of image contrast signal-to-noise ratio (SNR) and contrast-to-noise ratio 
(CNR) were calculated for each scan using the following formulas:  
              SNR= HUleft ventricle /  SDair 
           CNR= [ (HUleft ventricle - HUmyocardium) / SDair] 
 
Assessment of subjective image quality was performed by 2 observers. Image analysis was 
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performed individually, and image series were evaluated in random order.  
 Scans were classified using a Linkert scale in which a score of 3 was as very good, 2 was 
good, and 1 was poor or with significant artifact as per clinical practice at our institution. 
Statistical Analysis. Statistical analysis was performed using statistical software (MedCalc 
version 12.7.2; MedCalc Software, Ostend, Belgium; Stata version 13; StataCorp, College 
Station, TX). Parametric variables are expressed in terms of mean and standard deviation 
(SD), whereas nonparametric variables are expressed as median and interquartile ranges 
(IQRs). Comparison of the median ED between two groups was performed using Mann–
Whitney-U test, and between three or more groups using Kruskal–Wallis test. A p-value of 
<0.05 was considered significant.  
For the qualitative image assessment the inter-observer agreement was evaluated using 
Cohen’s kappa (κ) interpreted as follows: κ < 0.20 = slight agreement, κ: 0.21 − 0.40 = fair 
agreement, κ: 0.41 − 0.60 = moderate agreement, κ: 0.61 − 0.80 = substantial agreement, κ: 
0.81 − 1.0 = almost perfect agreement. 
 
Results 
Study population 
The study population included 47 patients (27 male, 20 female) with a mean of 7.6 ±5.5, 
years old. The most common primary indications for the CT examinations were aortic 
pathologies (n=15) and complex congenital heart diseases  (n=13). 
Spectrum of Radiation dose used 
The median age-specific ED in our study population was 2.2 mSv (range: 0.1–12.1 mSv).  
Patients scanned using a tube potential of 80 kV had a significantly lower median radiation 
dose (0.2 mSV; range 0.1-0.2 mSv) compared to patients who were scanned using a tube 
potential of 100 or 120 kV , p<0.001. The subjective image quality was reported on all clinical 
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CT reports. Overall, 25 (53 %) scans were reported as ‘‘very good’’, 21 (45 %) as ‘‘good,’’ and 
1 (2 %) as having significant artifact.  The agreement between the two different readers was 
substantial k= 0,88. 
In terms of objective image quality the mean SNR was 32.9, 30.2 and 28.3 at 120, 100 and 80 
kV respectively and there were not significant using the different kilovoltage (p=0.90). 
The mean CNR was 25.3, 19.4 and 20.3 at 120, 100 and 80 kV respectively (p=1.0). 
There were not significant differences according SNR and CNR in the different age-group 
patients. In particular the mean SNR was 45.4, 36.3 and 29.4 in 0–6, 6–12 and 12–18 age 
group respectively (p=0.664). The mean CNR was 27.7, 25.4 and 20.1 in 0–6, 6–12 and 12–
18 age group respectively (p=0.573)  
Discussion 
In this study we analyzed the assessment of cardiovascular CT in terms of radiation dose 
using a 64 slices scan in pediatric population with CHD. We demonstrated that using a dose-
saving protocol the overall (not-ECG gated and ECG gated CT) median dose is 2.2 mSv. Our 
results are in line with other studies in the literature: the dose founded in some studies was 
6.8 mSv [10] or 12 mSv [11] using a 64 slices scan and a retrospective gating.  
In the more recent literature the advent of new generation scanners is related with a drastic 
decrease of radiation dose in pediatric setting. Han et al [12] analyzed a cohort of 70 pediatric 
patients and found an average ED of 1.7 mSv for retrospectively ECG-gated CT and 0.9 mSv 
for prospectively ECG-triggered CT. These findings highlighted the increasing role of CT in 
the pediatric setting with CHD and put this technique as an important tool to try to avoid 
diagnostic angiography. In fact, it was demonstrated that in a population of neonates with 
complex CHD referred for diagnostic cardiac catheterization after initial assessment by 
echocardiography and CT none required additional imaging. This is a goal in terms of 
reduction of radiation dose considering the median of 13.4 mSv occurs for diagnostic 
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catheterization. 
Our study demonstrated that with a “standard” 64 slice scanner is possible to obtain good and 
diagnostic images. That is an important finding considering that the 64 slices remain the more 
diffused scanner. According to Italian registry of Cardiac Computed Tomography the 73% of 
scanner on national territory is a 64 slices [13]. In this scenario the impact of a dose saving 
protocol could be representing an important tool for the management of pediatric patient for 
the radiologist that works with a 64 slices scan. 
Our experience suggests, since no differences were found in terms of SNR and CNR between 
the different kilovoltage setting used (120,100 and 80 kV) that an 80 kV protocol is adequate 
to image most pediatric patients. Also the agreement between the two different observers 
involved in our studies is not conditioned by the kilovoltage used. 
The results of this study should be interpreted in view of its limitations. First then the number 
of patients is rather small and second because of the retrospective nature of the study. 
In conclusion, CT is a valuable imaging modality when evaluating pediatric patients with a 
large spectrum of known or suspected cardiovascular abnormalities. Using dose-saving 
techniques, CT protocols tailored to the pediatric population and growing expertise, a 
cardiovascular CT in children with a low radiation dose using a 64 slices scanner is now 
allowed routinely. 
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3. Papers on cardiac magnetic resonance imaging 
 3.1. Cardiac magnetic resonance before and after percutaneous pulmonary valve 
implantation (Radiol Med 2014) 
 
Purpose 
To measure the magnetic resonance (MR) artefact produced by a percutaneous pulmonary 
valve stent and to evaluate the changes in volumetric and functional right ventricle (RV) 
parameters due to percutaneous pulmonary valve implantation (PPVI). 
Materials and Methods 
Preliminary in-vitro study 
We studied a Melody ® valve measuring height of 24 mm and diameter of 22 mm inserted in 
a plastic box filled with echographic gel with common clinical cardiac sequences. The valve 
was oriented parallel to the main magnetic field in order to simulate the in-vivo orientation. 
Two readers (R1, R2), each of them with two years of experience in CMR, measured the size 
of signal void produced by the device artifact. Each of the two readers measured 16 values of 
diameter and 11 values of height. Mean, standard deviation, coefficient of variation (COV), 
and the difference between the size of signal void and the real valve dimensions were 
calculated.  
Study design and population 
After Institutional Review Board approval, we retrospectively analyzed our reports of pre-
/post-PPVI CMR studies performed from January 2008 to June 2010 in 27 consecutive 
patients (12 females, 15 males), aged 22±9 years (mean±standard deviation) treated with 
PPVI. CMR was performed at least one month before PPVI, and one, three, and six months 
after PPVI. All 27 patients underwent CMR before PPVI while not all patients performed all 
the three CMRs after PPVI: 13/27 patients were studied after one month, 20/27 after three 
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months, and 21/27 after six months.  
CMR protocol 
We used a 1.5-T unit with 40-mT/m gradient power (Magnetom Sonata Maestro Class, 
Siemens, Erlangen, Germany) and a four-channel cardio-thoracic coil. The same protocol was 
used before and after PPVI. Electrocardiographically (ECG)-triggered short-axis, four 
chamber, and long-axis images were obtained with a steady-state free precession sequence 
(true fast imaging with steady-state free precession, true-FISP) acquired with the following 
technical parameters: TR/TE=4/1.5 ms, FA=80°, thickness 7 mm and temporal resolution 45 
ms. A free-breathing turbo spoiled gradient echo sequence (fast low angle shot, FLASH) was 
performed for phase-velocity mapping of pulmonary flow with following technical parameters: 
TR/TE=4/3.2 ms, thickness 5 mm, velocity encoding from 150 to 350 ms, and temporal 
resolution 41 ms. Before PPVI the slice was located in the pulmonary conduit, perpendicular 
to the long vessel axis, immediately distal to the valve; after PPVI, the slice was located 4 mm 
distal to the stent artifact. 
Image analysis 
Cine true-FISP images on short axis plane, from hear base to the apex, were segmented 
semi-automatically (Syngo-Argus, version VE32B, Siemens Medical Solutions, Erlangen, 
Germany) by a reader with 6 years of experience in CMR imaging, to obtain ejection fraction 
(EF), end-diastolic volume (EDV) normalized to body surface area (EDV index, EDVI), and 
end-systolic volume index (ESVI) of RV and left ventricle (LV). Papillary masses were 
excluded from volume. Reverse flow, forward flow and peak velocity data of pulmonary valve 
were obtained segmenting phase-contrast flow images with the same software. We estimated 
pulmonary RF by flow data. Pressure gradient was estimated from peak flow velocities using 
Bernoulli’s equation. 
Catheterization and echocardiography 
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The peak-to-peak RV- PA gradient was calculated during this procedure as the difference in 
systolic pressure between RV outflow tract and main PA distal to the conduit before the 
implanting valve procedure. Before and three month after PPVI conduit mean pulmonary PG 
was calculated on echocardiography by tracing the border of continuous-wave spectral 
Doppler recordings and integrating the area under the curve. Maximum instantaneous PG 
was also estimated by echocardiography. 
Statistical analysis 
Differences between the two readers of the in-vitro study were tested with the Wilcoxon test. 
Wilcoxon test was also used to compare EDVI, ESVI, EF, RF and PG before and after PPVI. 
All testing was performed using SPSS statistical software for Windows, release 14.0 (SPSS 
Inc., Chicago, IL, USA). Values of p<0.05 were considered significant. 
  
Results 
Preliminary in-vitro study 
For R1 the mean diameter was 21.9±1.0 mm (COV=4.6%) and mean height was 25.0±0.8 
mm (COV=3.4%); for R2 the mean diameter was 22.1±1.3 (5.8%) and mean height was 
25.1±1.1 (4.5%). Pooling the data, the number of cases with an absolute measured-to-actual 
difference >1.5 mm was 5/27 (4/5 differences ≤2 mm) for both readers. The difference 
between the two readers was not significant for both the diameter (p=0.844) and the height 
(p=0.503). 
In-vivo study 
All CMR data and comparisons are showed in Table 1. 
Table 1 
CMR data before and 1, 3, and 6 months after percutaneous pulmonary valve implantation 
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 13 Patients 20 Patients 21 Patients 
 pre PPVI 1 month P pre PPVI 3 months P pre PPVI 6 months P 
RV EDVI 
(mL/m2) 71±20 70±23 0.506 83±42 66±22 0.013 79±42 64±21 0.050 
RV ESVI 
(mL/m2) 36±19 33±16 0.195 46±42 32±16 0.002 43±41 30±14 0.021 
RV EF (%) 50±10 55±13 0.065 47±14 53±14 0.031 49±13 54±12 0.018 
LV EDVI 
(mL/m2) 65±18 69±20 0.410 65±12 73±18 0.059 64±15 73±21 0.034 
LV ESVI 
(mL/m2) 30±11 31±10 0.916 31±9 31±9 0.613 30±9 33±4 0.508 
LV EF (%) 54.9±7 55.9±9 0.609 54±7 57±7 0.107 54±7 57±10 0.147 
RF (%) 15±19 1±3 0.025 12±13 2±4 0.01 14±18 2±5 0.013 
PG (mmHg) 34±18 11±10 0.003 31±19 15±15 0.001 36±15 13±15 <.001 
PPVI: percutaneous pulmonary valve replacement. RV: right ventricle. LV: left ventricle. EDVI: end-diastolic 
volume index. ESVI: end-systolic volume index. EF: ejection fraction. RF: regurgitation fraction. PG: pressure 
gradient. Data are presented as mean±SD. 
 
Considering 21 patients data before and 6 months after procedure, EDVI, ESVI and EF of RV 
before PPVI was 79±42 mL/m2, 43±41 mL/m2 and 49±13 % respectively; after PPVI was 
64±21 mL/m2 (p=0.054), 30±14 mL/m2 (p=0.021) and 54±12 % respectively (p=0.018). No 
significant differences were found in terms of LV ESVI and ejection fraction. We found a 
significant difference between EDVI before (64±15 mL/m2) and after (73±21 mL/m2) PPVI 
(p=0.034). Pressure gradient and RF before PPVI were 36±15 mmHg and 14±18 % 
respectively and after PPVI 13±15 mmHg (p<0.001) and 2±5 % (p=0.013). 
Before PPVI the mean gradient and the maximum instantaneous PG measured by 
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echocardiography were 38±7 mmHg and 76±14 mmHg respectively. The same data 3 months 
after PPVI were 16±9 mmHg and 27±15 mmHg respectively. Peak RV-to-PA gradient 
measured by catheter before PPVI was 41±17 mmHg. No significant differences were found 
comparing CMR PG, echocardiography mean PG (p=0.382) and catheter PG (p=0.586). 
Significant difference was found between echocardiography maximum instantaneous PG and 
CMR before (p=0.001) and after PPVI (p=0.010). 
Figure 1 shows LV EF, RV EF, RF and PG evolution before/after PPVI.  
Fig 1 
 
 
Discussion 
In patients with congenital heart disease, usually treated with many surgical procedures, to 
use a low-invasive procedure to treat the pulmonary valve or conduit dysfunction, such as 
PPVI, is a relevant clinical issue. This in-vitro/in-vivo study showed that: 1) the artifact from 
MR sequences is sufficiently small for not influencing qualitative and quantitative MR 
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evaluation after PPVI; 2) there is a significant reduction of PG and RF and a significant 
increasing of RV function. 
The low interobserver variability of the artifact size (COV 3.4-4.6%) showed the reliability of 
our measurements. Looking at the artifact size, we showed that SSFP, half-fourier acquisition 
single-shot turbo spin-echo (HASTE), and turbo spin-echo (TSE) sequences produced the 
most accurate valve measurement, i.e. less than 1.5 mm in the difference between the MR 
measures and the real size of the valve. This means that these MR sequences are suitable 
for clinical evaluation of the heart with Melody® valve as previously demonstrated for different 
type of vessel stents in an in vitro model [14].   
In the in-vivo study, we evaluated the pre-treatment and follow-up CMR study of patients 
treated with a PPVI. One month after PPVI we found a significant reduction of pulmonary PG 
and RF but no significant changes of RV volumes and EF.  The most probable reason is that 
the hemodynamic effect of PPVI needs more time than one month to be effective in terms of 
chamber volumes and pump function. In fact, both 3 months and 6 months after PPVI, we 
found a significant reduction of both diastolic and systolic RV volumes and a significantly 
increased RV EF, accordingly to literature data [15-18]. Regurgitation fraction was 
significantly reduced since the first control one month after PPVI and even PG decreased 
significantly, showing a good performance of the Melody® valve. 
Up to now, we found only a significant increase of EDVI for LV at 6 months after PPVI. No 
other significant differences were found for LV. This result plays in favor of a possible positive 
PPVI effect on LV function but further long-term studies are needed to confirm this 
hypothesis. 
RV EDVI and ESVI decreased during time and the RV EF reached a plateau. Conversely, a 
significant increase at this time of the LV EDVI produced a small but not significant increase 
of LV EF. Regurgitation fraction and PG remained below the clinical relevance after an 
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evident and significant drop down. 
Before PPVI, we did not found any significant difference between catheter and CMR PG 
values. However, when we use the catheter peak-to-peak PG as a reference standard for PG 
measured by CMR or echocardiography, we should consider that PG is calculated through 
the peak velocity both in echocardiography and CMR while catheter peak-to-peak PG is 
calculated as the difference between the maximal pressure in PA and in the RV which happen 
in two different time of the cardiac circle. Thus, catheter peak-to-peak PG could be 
inappropriate as a reference standard. Moreover, comparing the echocardiography maximum 
instantaneous PG to the CMR PG, we found a significant difference but no differences if 
comparing CMR PG to the echocardiography mean PG.  Therefore, it could be better to 
consider comparable the catheter peak-to-peak PG, the echocardiography mean PG and 
CMR PG. This could be a finding, which deserve further investigation. 
This study has some limitations. First, we studied a heterogeneous population with different 
congenital hear diseases traded with different surgical approaches. However all patients 
present the same condition of pulmonary stenosis/insufficiency treated with PPVI. Second, 
not all 27 patients performed completely a 3-step follow-up. However, the evaluation of 
patients for each follow-up step clearly showed the hemodynamic PPVI effect. Third, we did 
not estimate the inter- and intra-observer reproducibility of in-vivo CMR. However, CMR is 
commonly considered more reproducible than echocardiography in the evaluation of the right 
chambers, RVOT and pulmonary artery [19]. The last limitation of this study in that there is no 
a comparison with different pulmonary valve stent. 
In conclusion, the signal void produced in vitro by the metallic structure of Melody® pulmonary 
valve is limited to its inner space with a maximal extent to the external space equal to less 
than 5 mm. Moreover, CMR evaluation of patients after 6 months from PPVI shows a drastic 
decrease of RF and PG and a significant improvement of all RV parameters. CMR can be 
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used for a comprehensive noninvasive assessment of cardiac performance after PPVI. The 
long-term performance of Melody® pulmonary valve and its effect on the LV function remain 
to be investigated in further larger studies. 
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3.2 Segmentation of cardiac magnetic resonance cine images of single ventricle:  
including or excluding the accessorial ventricle? (Int J Cardiovasc Imaging 2014)  
 
Purpose 
Our aim was to compare two different approaches for segmentation of single ventricle (SV) on 
cardiac magnetic resonance (CMR) cine images. 
Materials and Methods 
Study Design and Population 
We retrospectively studied 30 patients (23 males and 7 females; aged 27±10 years) with 
diagnosis of SV malformation treated with systemic-pulmonary shunt or Fontan procedure. 
Thirteen of these 30 patients had an anatomic SV, while 17 a functional SV. In particular, the 
diagnosis before surgical intervention was: pure SV (n=13), tricuspid atresia (n=8), pulmonary 
atresia (n=5), mitral atresia (n=2), pulmonary stenosis with right ventricle hypoplasia (n=2). 
CMR Protocol 
We used a 1.5-T unit with 40-mT/m gradient power (Magnetom Sonata Maestro Class, 
Siemens Medical Solutions, Erlangen, Germany) and a four-channel cardio-thoracic phased-
array surface coil. Electrocardiographically-triggered steady-state free precession axial 
sequences (true fast imaging with steady-state free precession, FISP) were acquired with the 
following parameters: time of repetition (TR) ~ 4.3 ms, depending on the R-R interval of the 
cardiac cycle; time to echo (TE) 2.2 ms; flip angle (FA) 74°; 2 excitations; slice thickness 5 
mm; 40 no-gap slices; pixel size 1.4 mm × 1.4 mm; acquisition time 50 s. Half-Fourier single 
shot turbo spin-echo (HASTE) three-plane sequences were also acquired with the following 
parameters: TR~800 ms; TE 25 ms; FA=160°; slice thickness 6 mm. Cine short-axis, four 
chamber, and long-axis images were obtained with true-FISP sequences acquired with the 
following parameters: TR ~ 4 ms; TE=1.5 ms; FA=80°; thickness 8 mm; temporal resolution 45 
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ms. According to the clinical indications, flow sequences and/or MR-angiography were also 
performed. 
Image analysis 
We classified patients as having one or more of the following characteristics: 
- Visceroatrial situs: solitus (S), inversus (I), or ambiguous (A) 
- Orientation of cardiac axis: dextrocardia, or levocardia, or mesocardia 
- Ventricular loop: dextro (D)- or levo (L)-ventricle loop 
- Right or left morphology of the SV  
- Position of great arteries (GA): normal position (S) with aorta posteriorly and rightward 
to the pulmonary artery; inverted position (I) with aorta posteriorly but leftward to the 
pulmonary artery; D- or L-transposition (TGA) with aorta anteriorly to pulmonary artery 
and rightward or leftward respectively; or D- or L-malposition (MGA) when aorta is 
neither anterior nor posterior to pulmonary artery. 
Cine true-FISP images in short-axis plane were segmented semi-automatically (Syngo-Argus, 
v. VE32B, Siemens Medical Solutions, Erlangen, Germany) by a reader with 5 years of 
experience in CMR imaging. Ejection fraction (EF), indexed end-diastolic volume (EDVI), end-
systolic volume (ESVI) and stroke volume (SVI). Volume analysis was performed twice, firstly 
including only the systemic ventricle, secondly including both systemic and accessorial 
ventricles, blinding the reader to results of measurement of the first approach. 
Statistical Analysis 
Signed rank Wilcoxon test was used to compare EF, EDVI, ESVI and SVI obtained using the 
two different volume analyses. All calculations were performed using SPSS Statistics v. 19 
(SPSS, Chicago, IL) and Excel (Microsoft Excel® 2010, Redmond, WA). A p-value less than 
0.05 was considered as significant. 
Results 
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All patients were treated with the Fontan procedure, 12 with classic Fontan. Twenty-seven 
patients were found with situs solitus, 2 patients with situs ambiguus with asplenia and 1 situs 
ambiguus with polisplenia. Twenty-five patients had levocardia, 4 patients dextrocardia and 1 
mesocardia. Twenty-seven patients had D-ventricle loop and 3 L-ventricle loop. Four patients 
showed right morphology of the SV. We found 13 L-TGA, 4 L-MGA, 4 D-MGA, 3 D-TGA and 1 
inverted vessel position. At the volume analysis we excluded 3 patients due to a poor quality of 
the cine-MR images. Thus, 27 patients were analyzed. When segmenting both systemic and 
accessorial ventricles (Fig 2), EDVI and ESVI were significantly higher than those obtained 
segmenting only the systemic ventricle (Fig 2) while no significant difference was observed for 
the SVI. The EF obtained segmenting both systemic and accessorial ventricles resulted 
significantly lower than that obtained segmenting only the systemic ventricle. 
 
 
 
 
 
Fig. 2 
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Discussion 
Advances in pediatric cardiac care resulted in a population of adults with CHD being followed 
up in tertiary care centers, a part of whom undergoing a palliative or reparative surgery during 
their early life [20]. As reported by several studies [21, 22], we will face more and more with 
adults than with children affected with CHD, due to better diagnostic and therapeutic 
capabilities. Lifelong follow-up is required to optimize quality and span of life. Cardiac magnetic 
resonance plays a key role for CHD patients and has become routine practice during the last 
decade [21, 23]. Other than detailed anatomic views, CMR enables a functional assessment of 
ventricles, valves, and shunts, both qualitatively and quantitatively [23], sparing the patients 
with the ionizing radiation associated to computed tomography. Moreover, CMR in CHD 
patients usually does not require intravenous administration of contrast material (although 
contrast material can be safely used, if necessary) [21]. In this study, we analyzed the results 
of CMR performed in 30 patients with SV malformation treated with Fontan procedure. 
Anatomical analysis was successful in all patients, including the 3 subjects with low quality of 
cine MR images that impaired the functional analysis. Regarding volume analysis, we used 
two different approaches: (1) including only the systemic ventricle; (2) including both systemic 
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and accessorial ventricles. As expected, adding the accessorial ventricle to the systemic 
ventricle in the segmentation process, a significant increase in both EDVI (8 mL/m2, 19%) and 
ESVI (7 mL/m2, 25%) was observed, associated to an unchanged SVI (the difference was only 
1 mL/m2). Vice versa, the median EF was significantly lower (from 49% to 44%), allowing for 
speculating that the contribution of the accessorial ventricle to the pump function is negligible. 
Moreover, our result on the EF also implies that the longitudinal evaluation of these patients 
with CMR should be performed using always the same approach. In our opinion, due to the 
negligible absolute contribution to the SVI, we recommend that the accessorial ventricle should 
be ignored. Even in healthy subjects and Fallot patients a significant regional differences 
between the sinus and infundibulum components of the RV were demonstrated [24,25,26]. An 
important consideration, regarding our population, is that we pooled patients with “anatomic’’ 
single ventricle and ‘‘functional” single ventricle. In the first case there is an accessorial 
chamber and in the second a RV connected to the LV with a big interventricular septal defect. 
However, in both conditions there is only the systemic connection to the aorta without 
pulmonary connection; thus, we can consider these two groups of patients homogenous. 
Soriano and coauthors [27] studied a sample of young patients with SV (mean age 7 months), 
comparing three-dimensional echocardiography measurements of SV volume, mass and EF 
with those measured by CMR. Their segmentation methods of CMR images were not 
completely described but the accessorial ventricle was not specifically mentioned [26]. Our 
study has limitations. Firstly, this is a retrospective study on a relatively small number of 
subjects, based on a single-center historical series of SV patients. However, this was a 
consecutive series of a relatively rare disease. Second, only one reader examined CMR 
images and we did not estimate intra-observer reproducibility of volume measurement (the 
evaluation was performed by the most experienced radiologist routinely dedicated to cardiac 
imaging). 
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In conclusion, CMR is an optimal technique to define the correct cardiac anatomy and function 
of SV patients. Our findings support the hypothesis that the accessorial ventricle does not 
contribute to the pump function. Physicians should be aware that the inclusion of the 
accessorial ventricle in the segmentation post-processing may lower the EF. 
 26 
3.3 A geometric index to differentiate abnormal from normal septal wall motion  
on cardiac MR imaging (Acta Radiol 2015) 
 
Purpose: The definition of abnormal septal wall motion (SWM) is usually performed on a 
subjective visual assessment with cardiac MR (CMR). 
Material and Methods 
Population 
Local Ethics Committee approval was obtained for this retrospective study, including a 
consecutive series of 100 patients who underwent CMR examination at our institution from 
September 2009 to March 2010. They were 73 males and 27 females (mean age±standard 
deviation 43±22 years).  
CMR Imaging Protocol 
All examinations were performed with a 1.5-T MR unit with 40-mT/m gradient power 
(Magnetom Sonata Maestro Class, Siemens Medical Solution, Erlangen, Germany) and a 4-
channel phased-array surface coil. Cardiac kinetics was evaluated on cine 4-chamber and 
short-axis planes obtained with unenhanced balanced steady-state free precession sequence 
acquired with the following technical parameters: time of repetition  ~4.3 ms, depending on the 
R-R interval of the cardiac cycle, time of echo 1.5 ms, flip angle 80°, slice thickness 7 mm, 
retrospective ECG-trigger. Morphology was assessed with an ECG-triggered unenhanced 
balanced steady-state free precession sequence on axial plane with the following technical 
parameters: time of repetition ~4.3 ms, depending on the R-R interval of the cardiac cycle, time 
of echo 1.1 ms; acquisition time ~ 1 minute, field of view 275×400 mm2, slice thickness 5 mm. 
Image Analysis 
All CMR examinations were independently reviewed by two readers with 4 (R1) and 2 (R2) 
years of experience in CMR. For each patient, R1 performed both qualitative and quantitative 
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analysis on mid-ventricular short-axis images. For qualitative analysis, R1 analyzed the septal 
convexity and subjectively defined whether an abnormal SWM was present at the end-systolic 
and/or end-diastolic phases on short axis images. For the quantitative analysis, R1 measured 
the septum curvature at least one week before or after the qualitative analysis, applying the 
following protocol (Fig. 3): 
1. selection of the mid-ventricular slice on short axis slice; 
2. measurement of the distance from anterior to posterior septal RV/LV junctions (defined 
as the connection between anterior or posterior RV and LV wall in the septum) applying 
a ruler perpendicular to the endocardial surface (segment a in Fig. 3); 
3. measurement of the maximal distance from the endocardial septum surface 
perpendicularly to the segment a (segment b in Fig. 3);  
4. calculation of the b/a ratio, that was used as a measure of the convexity septal index 
(CSI) of the interventricular septum. 
 
 
Fig. 3 
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This measurement protocol was applied both in end-systolic and end-diastolic phases. The 
coronary sinus diameter was measured using axial ECG-triggered unenhanced balanced 
steady-state free precession sequence. Using the middle 4-chamber plane at end-systolic 
phase, the right atrium area was also measured. In order to estimate the inter-reader 
reproducibility, R2 repeated the qualitative and quantitative CSI diastolic evaluation.   
Reference Standard and Statistical Analysis  
Inter-reader reproducibility was estimated using Cohen κ statistics for qualitative analysis and 
Bland-Altman method for quantitative analysis. Referring to differences between the two 
datasets (R1 – R2) of quantitative analysis, the coefficient of repeatability (CoR) was 
calculated as: 
CoR=1.96 × Standard Deviation (R1–R2) 
And reproducibility was calculated as: 
100
R2)Mean(R1,
CoR1ilityReproducib ×⎥
⎦
⎤
⎢
⎣
⎡
−=  
where Mean(R1,R2) is the grand mean calculated using values obtained by the two readers.  
Referring to the qualitative visual analysis, the study sample was retrospectively subdivided in 
three groups, as follows: group A, including patient with normal SWM; group B, including 
patients with abnormal SWM only at end-systolic phase; group C, including patients with 
abnormal SWM at both end-systolic and end-diastolic phases. The comparison of the median 
CSI among the three groups of patients was performed using the Kruskall-Wallis test, while the 
paired comparisons were performed using the Mann-Whitney U test. The CSI trend among the 
three groups was tested using the Jonckheere-Terpstra test. The same strategy was applied 
for the coronary sinus diameter and the right atrium area. We estimated the interstudy 
variability in a volunteer who repeated CMR nine times. To this end, R1 measured the septum 
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curvature at the same level in short axis images. Interstudy variability was expressed in terms 
of coefficient of variation, i.e. the ratio between the standard deviation and the mean of the 
nine measurements. The correlation among end-systolic CSI, coronary sinus diameter, and 
right atrium area was estimated using the Spearman correlation coefficient. This analysis has 
been repeated for end-diastolic CSI. Continuous variable were presented as median and 
interquartile interval. P-values lower than .05 were considered significant. All testing was 
performed using SPSS statistical software for Windows, release 17.0 (SPSS Inc., Chicago, IL). 
Results 
Out of 100 patients, 73 were diagnosed with a normal SWM at qualitative visual evaluation 
(group A). Of the remaining 27 patients, 9 showed an abnormal SWM at end-systolic phase 
(group B), and 18 at both end-systolic and end-diastolic phases (group C). Two patients had a 
negative CSI, associated with a paradoxical abnormal SWM. The time for the visual analysis 
was about 3 minutes, that for quantitative analysis about 4 minutes (including CSI calculation 
for both phases). 
Inter-reader reproducibility and interstudy variability 
Cohen κ coefficient for the inter-reader reproducibility of qualitative evaluation resulted to be 
almost perfect (k=0.841, p<0.001). Regarding quantitative analysis, CoR obtained using the 
Bland-Altman method was 0.05, corresponding to an inter-reader reproducibility of 77%. The 
coefficient of variation of the interstudy variability estimated on the volunteer was 15% in 
diastole and 9% in systole. 
Convexity septal index in normal and abnormal subjects at visual evaluation 
At end-systole, the median CSI was 0.23 for group A (normal subjects at visual evaluation), 
significantly higher than that (0.13) of group B (abnormal SWM at visual evaluation only at end-
systole), and that (0.10) of group C (abnormal SWM at visual evaluation at both end-systole 
and end-diastole).  Similarly at end-diastole, when the median CSI was 0.25, 0.15, and 0.12, 
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respectively. The CSI trend among the three groups was significant, at both phases. The 
median coronary sinus diameter of group A (8 mm) was significantly smaller (p=0.009) than 
that of group C (median 11 mm); although the trend for the coronary sinus diameter along the 
three groups was significant (p= 0.007), the comparisons between group A and group B and 
between group B and group C were not significant. The median right atrium area was not 
significantly different among the three groups of patients (p= 0.246). 
Correlations 
Coronary sinus diameter resulted positively correlated with right atrium area (r = 0.332, P= 
0.001). At bivariate analysis, while end-systole CSI negatively correlated with both right atrium 
area (r = -0.197, p= 0.049) and coronary sinus diameter (r = -0.245, p= 0.015), end-diastole 
CSI showed a trend towards significance or a borderline P value for negative correlation with 
right atrium area (r = -0.164, p= 0.104) and coronary sinus diameter (r = -0.193, p= 0.056).  
Discussion 
Abnormal SWM consists of the interventricular septum moving anteriorly during systole. It 
occurs when the heart center of gravity is shifted into the RV because of its volume and/or 
pressure overload [28]. Many conditions, congenital or not, may cause abnormal SWM. 
Examples include Fallot tetralogy, transposition of great arteries, congenital absence of 
pericardium, septal ischemia or infarction, left branch bundle block, constrictive pericarditis, 
and valve disease [29]. In clinical practice, the SWM can be evaluated with M-mode or color-
tissue Doppler echocardiography [28]. Using color-tissue Doppler, the wall motion toward the 
probe is colored red, whereas the wall motion away from the probe is colored blue. In 
abnormal SWM, the point of the color change shifts towards the apex [29]. Another technique 
to assess SWM is the gated single-photon emission tomography with perfusion tracers using 
regional wall motion assessment [29]. However, echocardiography and single-photon emission 
computed tomography have suboptimal performance due to the possibility of poor acoustic 
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window and relatively low spatial resolution, respectively [28]. Several authors [30,31] reported 
on the use of CMR for this purpose. CMR with cine sequences is considered the most reliable 
technique for quantitative evaluation of cardiac function, outperforming other techniques in 
terms of reproducibility, without exposure to ionizing radiation. Systolic SWM reflects a 
condition of pulmonary stenosis or pulmonary hypertension; conversely diastolic SWM reflects 
a right ventricle volume overload. In this study, we defined a geometric index, the CSI, for 
measuring the septal convexity at CMR in order to distinguish normal from abnormal SWM. 
We tested CSI both in end-systolic and end-diastolic phases and evaluated its value in three 
different groups of patients on the basis of qualitative, visual global evaluation of SWM. The 
excellent inter-reader reproducibility (κ = 0.841) of this qualitative visual evaluation reinforced 
our use of their results for subdividing the patients in the groups. In this study, 27 of 100 
patients showed abnormal SWM at visual evaluation. Almost half of them (n = 12, 44%) had a 
pulmonary valve stent implantation, this subgroup of patients having the highest prevalence 
(80%) of abnormal SWM, as expected. In fact, patients needing a pulmonary valve stent 
implantation are mainly those presenting with a valve regurgitation (associated or not 
associated with a valve stenosis). This condition may cause a RV pressure and/or volume 
overload and, as a consequence, an abnormal SWM, as demonstrated by Roeleveld et al. who 
showed a pulmonary arterial pressure higher than 67 mmHg in patients with abnormal SWM 
[32]. 
We found a significant difference in end-systole CSI between group A not only if compared 
with group C but also with group B. This result confirms that our geometrical approach works 
to quantify the SWM but does not seem to add “anything else” than quantification. Its 
mathematical definition determines the negative CSI value when the septum has a paradoxical 
bowing towards the left chamber, as we had in two patients. Obviously, when CSI is exactly 
equal to 0, the septum is perfectly flattened (one case, in systolic phase, in our series).  
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Interestingly, we found also for end-diastole CSI a significant difference not only between 
group A and group C, but also between group A and group B. This last result opens an 
intriguing window. In fact, end-diastole CSI seems to allow for detecting an abnormal SWM in 
patients with normal SWM at visual evaluation. We can speculate that this occurs because an 
abnormal SWM in systole could generate a minimal SWM alteration even in diastole that could 
be detected by quantification with CSI only. As a confirmation of this finding, no significant 
differences were found comparing group B and group C both at end-systole and end-diastole.  
Coronary sinus diameter was significantly smaller in group A than in group C and no significant 
differences were found between group A and group B for this variable. We can speculate that 
a volumetric and/or pressure RV overload, analyzed with visual assessment, produces an 
enlargement of coronary sinus. At correlation analysis involving CSI at end-systole, we found a 
significant negative association between CSI and the coronary sinus diameter and the right 
atrium area, separately. From these results, one may conclude that the lower the CSI (i.e., the 
more abnormal is SWM), the larger the right atrium area and the coronary sinus diameter. 
Thus, the right atrium area resulted associated to the coronary sinus diameter regardless the 
presence of an abnormal SWM. This is a consequence of a pressure overload in particular 
regarding our patient’s sample (89% of patients with abnormal SWM had congenital heart 
diseases). At correlation analysis involving CSI at end-diastole, we found a negative 
correlation with a trend towards significance or borderline significance between CSI and right 
atrium area or coronary sinus diameter, probably due to a too small sample size. This is not 
the first approach to quantify SWM proposed in the literature. Using Doppler echocardiography 
Louie et al. [33] presented a geometric index to quantify the ventricular septal displacement in 
11 patients who underwent tricuspid valvulectomy. This was a left ventricle eccentricity index 
of the short-axis profile, calculated at end-systole, mid-diastole, and end-diastole. A more 
recent study by Mori et al. [34] showed another left ventricle eccentricity index derived from the 
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ratio of two short-axis diameters measured at early diastole in 32 consecutive patients with 
pulmonary hypertension. Apart from the relatively small sample size of both studies including 
single disease and the use of echocardiography, these two indices have slight differences in-
between them, both including the length between the septum and the left free wall. This 
implies a high dependence on what happens to the entire left ventricle than what happens to 
the septum. In fact, both of them were named “eccentricity” indices while what we are 
presenting here is a “convexity septal index”. In 2005, Roeveled et al. [32] proposed an 
interesting method to evaluate the septum curvature and correlate it with systolic pulmonary 
arterial pressure in patients with pulmonary hypertension using CMR. The septal curvature 
was measured in the short-axis image plane at the most basal level and was defined as the 
reciprocal of radius of curvature. However, the main aim of this method, based on an analytic 
calculation, was to predict whether in a specific population of patients with systolic pulmonary 
arterial pressure > 67 mm Hg there was a leftward septal curvature. The potential advantage of 
our CSI if compared with that method of evaluation of septal curvature is its simplicity and the 
short time needed to obtain it (only 4 minutes, compared to 3 minutes for visual evaluation). 
Our study has three limitations. First, this is a retrospective study. The CSI should be 
prospectively tested in large consecutive series of patients with different cardiac diseases and 
clinical conditions. Second, the sample size was relatively small, even if composed by a 
consecutive series with a relatively high rate of abnormal SWM (27%) which allowed for a first 
demonstration of the method. Third, we did not estimate intra-observer reproducibility, which 
could be even better than the inter-observer reproducibility (77%), allowing for a highly reliable 
longitudinal evaluation of these patients by an individual reader. 
In conclusion, this study supplies a proof of concept that end-systole and and-diastole CSI 
enable us to quantify SWM at CMR in a simple, easy, and reproducible way. Moreover, end-
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diastole CSI seems to be sensitive in detecting an abnormal SWM in patients with apparently 
normal SWM at visual evaluation.  
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3.4. Four-year cardiac magnetic resonance (CMR) follow-up of patients treated with 
percutaneous pulmonary valve stent implantation (Eur Radiol 2015) 
 
Purpose 
To investigate follow-up after percutaneous pulmonary valve implantation (PPVI). 
Materials and Methods 
Study design and population 
After institutional review board approval which waived specific patient consent for data 
analysis, we retrospectively retrieve prospective reports of CMR examinations performed 
before and after PPVI from January 2008 to June 2014 in 40 consecutive patients treated with 
a Melody valve stent (Medtronic, Inc., Minneapolis, MN, USA). CMR had been planned at least 
1 month before PPVI, and 1, 3, 6, 12, 24, 36, and 48 months after PPVI. Pediatric cardiologists 
obtained informed consent for the intervention and use of this type of valve for PPVI. Informed 
consent was obtained by each patient for the injection of Gd-based contrast material, when 
administered. 
CMR protocol 
We used a 1.5-T unit with 40-mT/m gradient power (Magnetom Sonata Maestro Class, 
Siemens, Erlangen, Germany) and a four-channel cardio-thoracic phased-array coil. The same 
imaging protocol was used before and after PPVI. CMR mean duration was 45±10 min. 
Electrocardiographically-triggered short-axis, four-chamber and long-axis images were 
obtained with a breath-hold steady-state free precession (SSFP) sequence (true fast imaging 
with SSFP, true-FISP) acquired with the following technical parameters: TR/TE, 4.0/1.5 ms; 
FA, 80°; slice thickness, 7 mm; temporal resolution, 45 ms; mean acquisition time 14±4 s. A 
breath-hold turbo spoiled gradient echo sequence (fast low-angle shot, FLASH) was performed 
for phase-velocity mapping of pulmonary flow with the following technical parameters: TR/TE, 
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4.0/3.2 ms; slice thickness, 5 mm; velocity encoding (VENC) from 150 to 350 ms; temporal 
resolution, 41 ms; mean acquisition time 15±4 s. Firstly we acquired the phase-contrast 
sequence with a VENC of 150 ms; in the presence of aliasing, we modified the VENC adding 
50 ms for each new sequence, step-by-step up to the complete disappearance of the aliasing 
artifact. Before PPVI, the slice of phase-contrast sequence was located in the pulmonary 
conduit, perpendicular to the vessel long axis, immediately distal to the valve; after PPVI, the 
slice was located at least 4 mm distal to the stent artifact to avoid contamination of images 
from the metallic artifact. Conventional angiography with a three-dimensional gradient-echo 
fast low-angle shot sequence (FLASH, TR=3.32 ms, TE=1.21 ms, flip angle 25°, slice 
thickness=1.5 mm, 72 partitions, acquisition time 21 s) after injection of 0.1 mmol/kg of 
gadobenate dimeglumine (MultiHance, Bracco Imaging SpA, Milan, Italy) was performed only 
at the baseline CMR before PPVI. MR angiography was not performed after PPVI due to the 
presence of metal artifact in the pulmonary conduit. 
Image analysis 
Cine true-FISP images in the short-axis plane, from heart base to apex, were segmented 
semiautomatically (Syngo-Argus, version VE32B, Siemens Medical Solutions, Erlangen, 
Germany) by a reader with 7 years of experience in CMR imaging, to obtain end-diastolic 
volume (EDV) normalized to body surface area (EDV index, EDVI), end-systolic volume index 
(ESVI), stroke volume (SVI), and ejection fraction (EF) of RV and left ventricle (LV). Papillary 
muscles were excluded from the volume. The basis was chosen with the references of 4-
chamber view. Reverse flow, forward flow and peak velocity data of the pulmonary valve were 
obtained by segmenting phase contrast images with the same software. We estimated 
pulmonary regurgitation fraction (RF) by flow data. The pressure gradient (PG) was estimated 
from peak flow velocities using Bernoulli’s equation as described. 
Statistical analysis 
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Friedman test was used to compare EDVI, ESVI, SVI, EF, RF and PG before and after 1, 3, 6, 
12, 24, 36, and 48 months from PPVI. All testing was performed using SPSS statistical 
software for Windows, release 14.0 (SPSS Inc., Chicago, IL, USA). P values lower than 0.05 
were considered as significant. 
Results 
Overall, PG (31±06 to 16±4 mmHg), RF (16 ±17 to 0.3±1 %) significantly declined (p<0.001). A 
significant reduction of RV volumes (EDVI from 82±38 to 58±12 ml/m2, p<0.001; ESVI from 
44±12 to 30±13 ml/m2, p<0.001), as well as a significant increase of RVEF (from 49±13 to 
58±12%, p<0.001) and SVI (from 38±14 to 40±8 ml/m2, p<0.001) was observed; RF and PG 
were significantly reduced at last follow-up (p<0.001). LV analysis showed a significant 
increase in EDVI (from 67±17 to 73±18 ml/m2, p=0.034) and SVI (from 37±11 to 43±10 ml/m2, 
p<0.001) while no significant changes were observed for ESVI and EF. One patient performed 
CMR with intracardiac defibrillator with the housing implanted on the right anterior side of the 
chest (Figure 4). Before CMR examinations, a dedicated cardiologist deactivated the device to 
avoid a wrong response during the examination. 
 
 
Fig. 4 
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Two patients needed a surgical replacement of conduit after 24 and 36 months from PPVI 
respectively, due to a fracture of pulmonary stents. One patient needed a second implantation 
of a stent in pulmonary conduit after 24 months of PPVI due to a restenosis of the valve. We 
did not find any CMR sign or parameter that could predict the adverse events.  
Discussion 
In the last decade PPVI has emerged as the preferred treatment in pulmonary conduit 
dysfunction in CHD patients, being less invasive than surgical repair. We investigate with CMR 
a consecutive series of patients before and after PPVI to evaluate the immediate and mid-term 
changes in cardiac function values. We observed a significant and progressive reduction of RV 
volumes as well as a significant increase of RVEF and RVSVI during the investigated follow-
up. The most important remodeling occurred by 3 months from PPVI. However, it was 
important to show what happened during following four years, when a further progressive 
remodeling was observed with a continuous increase of RVEF. Regarding flow analysis, both 
RF and PG were strongly reduced immediately (at 1 month follow-up) and thereafter stable at 
lowered values. These results were in agreement with literature [53, 54, 55], showing a good 
effect of PPVI on the RV function. However, to our knowledge, there are no studies showing 
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the follow-up of these patients up to 4 years after PPVI. 
Interestingly, follow-up of LV volumes showed a significant increase in EDVI and SVI. The 
former result can be explained considering that the reduction of RVEDVI allows for a better 
diastolic compliance of LV, in turn determining an increased LVSVI. The improvement of 
LVEDVI likely reflects a decrease in RV volume and pressure overload, and hence reduction in 
consequent interventricular dependence from paradoxical septal motion. Conversely, the LVEF 
remained unchanged due to the not significant increase in LVESVI. Of note, one patient with 
an intracardiac defibrillator was fully studied with CMR with a comprehensive evaluation of RV 
and RV outflow tract function. The reason for this good result is that the housing of the device 
was implantated on the right side of the chest, causing artifacts not influencing heart imaging. 
This CMR was performed because the patient has been enrolled in an IRB-approved 
prospective study aimed at evaluating the MRI safety in patients having pacemakers or 
intracardiac defibrillators. PPVI implies some possible complications as stent fracture [35] or 
endocarditis [36]. In our population, two patients had stent fracture and one had endocarditis 
and stent restenosis. In the two cases of stent fracture a surgical implantation of a conduit was 
performed; in the case of restenosis a new stent was implanted. We did not find any CMR sign 
or parameter that could predict the adverse events, being the baseline and follow-up results 
not different from those patients who did not have any adverse events. Thus, while 
endocarditis is the most probable cause of restenosis, the only possible explanation for the 
fracture is a suboptimal correspondence between the stent geometry and the individual outflow 
tract anatomy. This study had some limitations. First, we retrospectively evaluated a 
heterogeneous sample of patients with congenital heart diseases originally treated with 
different surgical procedures. However, the series of patients was consecutive and all patients 
presented the same condition of pulmonary stenosis/insufficiency treated with PPVI. Second, 
we did not estimate the inter- and intra-observer reproducibility of CMR data. However, CMR is 
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widely considered more reproducible than echocardiography in the evaluation of the right 
chambers and pulmonary artery in a multiplanar and comprehensive evaluation [36]. Finally, 
only one type of pulmonary valve stent as described in Methods, so that our conclusion cannot 
be applied to other pulmonary valve stents. 
In conclusion, a CMR four-year follow-up after PPVI demonstrated restored pulmonary conduit 
function, reduced RV volumes and increased RV and LV function. However, it did not predicted 
valve fracture/restenosis.   
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3.5.  Semi-Automated Blood-threshold CMR Volume Analysis of Functional 
Univentricular Heart (Under revision) 
 
Purpose 
To validate a semi-automated blood-threshold (BT) segmentation software of cardiac magnetic 
resonance (CMR) cine images in patients with functional univentricular heart (FUH). 
Materials and methods  
Study population 
The Ethics Committee approval was obtained for this retrospective study. A total of 70 CMR 
exams of patients with FUC performed at our institution between March 2008 and March 2015 
were considered. The inclusion criteria for the re-assessment of the images were: 1) complete 
acquisition of cardiac volume with cine images and 2) acquisition of through-plane images of 
flow ascending aorta. Therefore, 15 exams were excluded, for a total of 55 exams remaining, 
obtained from 44 patients (7 patients were scanned 2 times, 2 patients 3 times). In case of 
repeated exam in the same patients, the time interval was at least 12 month. They were 30 
males and 14 females with a mean age at the first examination of 25 years ±8 standard 
deviation. The youngest patient was 7 years old at the time of the examination, the oldest 
patient was 41 years old. 
Image acquisition 
All CMR examinations were performed with a 1.5-T unit (Magnetom Sonata Maestro Class or 
Magnetom AERA, Siemens Medical Solutions) with 40-mT/m or 35-mT/m gradient power 
respectively, using a four- or twelve channel surface phased-array coil placed over the thorax 
and with the patient in supine position. The image acquisition was gated to the ECG signal and 
respiration control (breath-holding) to produce a cine sequence throughout all the systole and 
diastole and to avoid cardiac and respiratory artifacts. A CMR study included a complete set of 
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short-axis (from base to apex) cine images, using an ECG-triggered steady-state free 
precession pulse sequence acquired with the following technical parameters: TR/TE 4.0/1.5 
ms; FA 80°; slice thickness 8 mm; time resolution 45 ms; mean acquisition time 14±4 s. The 
phase contrast (PC) through-plane sequences were used for blood flow quantification. Images 
perpendicular to the ascending aorta were obtained. A breath-hold turbo spoiled gradient echo 
sequence (fast low-angle shot) was performed for phase-velocity mapping with the following 
technical parameters: TR/TE 4.0/3.2 ms; slice thickness 5 mm; velocity encoding (VENC) from 
150 ms to 350 ms; time resolution 41 ms; mean acquisition time 15±4 s. Initially, we acquired 
the PC sequence with a VENC of 150 ms. In the presence of aliasing, we modified the VENC 
adding 50 ms for each new sequence, step-by-step up to the complete disappearance of the 
aliasing artifact. Flow measurements were performed right above the aortic valve. The PC 
through-plane sequences produced two sets of images: the magnitude image and the phase 
velocity map. The magnitude image provides details on the anatomy and identifies the 
boundaries of the vessel, while the phase velocity map corresponds to blood velocity [39]. 
Image assessment 
Two independent readers with comparable experience (2 years) performed the segmentation 
of cardiac and flow images using MEDIS QMass 7.6 and QFlow 5.6 (Medis medical imaging 
systems, Leiden, The Netherlands. For the segmentation of cardiac images, in each session 
both readers independently manually traced the epicardial contour of the FUH both in the end-
diastolic and end-systolic phases. Then the software applied the blood threshold technique 
(Mass-K mode) and calculated the end-diastolic volume (EDV), end-systolic volume (ESV), 
SV, ejection fraction (EF) and cardiac mass values in a totally automated way. For the 
segmentation of flow images of the ascending aorta, in each session the reader positioned a 
region of interest on the vessel boundary of a selected slice. Subsequently, the reader 
propagated the segmentation through the remaining slices and the software proposed an 
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automated adjustment and the reader was allowed to manually correct the adjusted contours. 
For each session forward flow and backward flow measurements were obtained. 
Statistical analysis 
The Wilcoxon method and Spearman correlation were used respectively to compare and 
correlate the median value of SV and aortic forward flow. The Bland-Altman method was used 
to estimate the intra- and inter-reader reproducibility. The intra-reader reproducibility was 
performed only for R1 with at least a 10-day interval between the two sessions. The coefficient 
of repeatability (CoR) was calculated as 1.96*standard deviation of differences of the two 
datasets. Reproducibility was reported as complement to 100% of the ratio between the CoR 
and the mean. Bias (mean of the differences of the two datasets), and 95% limits of agreement 
(bias ± 2 SD) were plotted as well. 
Results 
The image analysis was feasible in all patients and no artifacts prevented from a correct 
segmentation. The time needed for segmentation of cine and PC images was 15±2 minutes 
per exam. 
Fifty-five exams were analyzed. The median value of SV and aortic forward flow were 57.7 ml 
(47.9–75.6) and 57.4 ml (48.9–80.4) respectively. We found a not significant difference (P 
=0.123) but a significant correlation (r=0.789, P <0.001) between mean SV and aortic forward 
flow. 
The mean difference between the SV values measured by R1 was 0.12 ml accompanied by a 
CoR of 8.10 ml, corresponding to an intra-reader reproducibility of 86%.  The mean difference 
between the aortic forward flow values was -0.1 ml accompanied by a CoR of 2 ml, 
corresponding to a reproducibility of 96%. 
The inter-reader analysis of SV showed a CoR of 8.63 ml over a mean difference of -1.9 ml, 
corresponding to an inter-reader reproducibility of 85%; the same data for the aortic forward 
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flow were 2.12 ml over a mean difference of 0.24 ml corresponding to and inter-reader 
reproducibility of 96%. An example of segmentation of cine-images with threshold technique is 
shown in Figure 5 
Fig. 5 
 
 
Discussion 
Practical and theoretical advances in the treatment of FUH and in the clinical management of 
FC have greatly increased life expectancy of these patients. Physicians are now confronted, as 
in other forms of CHD, with a steady growing population of young and middle aged adults 
living on FC. This population requires a strict clinical follow-up to prevent or at least delay the 
onset of a large spectrum of complications, ultimately leading to a life-threatening failure of the 
FC and to the need of heart transplant [37]. The pivotal role of cardiac imaging in this rigorous 
strategy of follow-up has been widely demonstrated, and so have been the considerable 
advantages of CMR compared to other imaging techniques that could be used to perform a 
functional or anatomical evaluation of FC, namely echocardiography and computed 
tomography (CT) [38]. Constant advances in CMR techniques and equipment in the last 
decade grant now adequate anatomical detail in addition to the accurate and not operator-
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dependent functional assessment of ventricular chambers (main and accessory), cardiac 
valves and intra or extra-cardiac shunts and conduits. Furthermore, the routine use of CMR in 
the imaging of FC not only does not usually require the intravenous administration of contrast 
mediums, but also conveniently restricts the use of CT and therefore patient’s exposure to 
ionizing radiation to occasional circumstances that require a very highly detailed anatomical 
assessment of the FC [39]. Volume and function assessment is achieved through the 
segmentation of cine images. This post-processing technique, that in its first applications was 
exclusively manually performed by a trained reader, implies the recognition of the difference 
between the blood pool in the ventricular cavity, other anatomical structures normally in the 
ventricular chamber such as trabeculae and papillary muscles (TPM) and the ventricular walls. 
Manual tracing of contours for the ventricular walls and TPM by an experienced reader still 
constitutes the most widely validated and employed approach, but in the last decade several 
studies have validated semi-automated techniques that, while less time-efficient than a fully 
automated solution, try to address its numerous limitations and provide a solid method, well-
balanced in terms of cost-effectiveness analysis, to obtain a proper estimate of ventricular 
volume and mass with minimal manual input [40]. One of these limitations is the correct 
allocation of TPM to the myocardial mass. TPM were shown to substantially influence the 
accuracy of ventricular volume and mass assessment, but the exclusion of TPM from the blood 
pool obtained with a painstaking manual tracing of endocardial contours results in a greatly 
increased length of the post-processing stage and presents an high intra- and inter-reader 
variability, resulting in a customary misattribution bias for TPM when the fully manual tracing of 
contours is employed [41–43] . A BT technique such as the Mass-K Mode algorithm can serve 
as a time-saving and accurate solution to this notable issue. In this technique, after the reader 
has manually traced only the epicardial contours on the end-systolic and end-diastolic phases 
of the cine-images, the software calculates a blood percentage for each pixel inside the 
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contoured area considering the different signal intensity of blood and myocardium. After visual 
inspection, the reader can freely alter, in any slice and phase, the default threshold value 
(50%) of signal intensity discrimination. Moreover, semi-automated detection of the epicardial 
margin can be used, requiring only small manual adjustments in good quality images and thus 
further curtailing the time required for the post-processing stage [43]. The Mass-K Mode 
algorithm has been validated for clinical routine application, showing both accurate and 
reproducible evaluation of ventricular mass and volume and reduced time of analysis, by 
Jaspers et al. [82] on phantoms and 12 patients with normal cardiac anatomy and function and 
more recently by Varga-Szemes et al. [40] on 137 patients with a broad range of cardiac 
diseases but not affected by CHD. The results of our study validate the use of this blood-
threshold technique in patients with a thoroughly abnormal cardiac anatomy, such as the one 
that is found in patients with FC. In the absence of other reference tools to validate ventricular 
volume assessments, we choose to use aortic flow measurements as an independent 
benchmark for SV since previous studies showed it to be a solid and reproducible standard 
and we found no statistically significant difference and a significant correlation between the two 
value. Moreover, greater level of automation and lesser need of manual adjustments granted 
by the use of the blood threshold technique and the semi-automated recognition of epicardial 
contours and of aortic walls account for the excellent inter- and intra-reader reproducibility of 
both SV and aortic flow volume, respectively around 85% and 96%.  
Our study has limitations: first, it is a retrospective study on a relatively small number of 
subjects and is based on a single-center historical series of FC patients; however FUV patients 
are a very small population and usually referred to a single center. Second, it is possible that, 
due to the retrospective structure of our study, even small differences in the acquisition 
parameters, reasonably likely to happen in the absence of standardized CMR acquisition 
protocol, may have negatively influenced the quality of cine-images and therefore the 
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performance of the BT technique. Third, the study lacks an independent reference standard, 
even though the aortic flow analysis may be considered substantially independent from the 
cardiac cine study.  
To summarize, we successfully validated the use of a BT technique for the segmentation of 
cine-images in patients with FC. We observed a high intra- and inter-reader reproducibility for 
the assessment of ventricular stroke volume and excellent agreement with aortic flow values 
used as benchmark. In routine clinical and diagnostic practice, the shortening of post-
processing and the accurate quantification of cardiac function may have a positive impact on 
the follow-up of patients with FC. 
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4. Conclusions 
We contributed to show the possibility, using dedicated protocols, to obtain an impressively 
low ionizing dose reduction in CHD patients also using standard 64-slice CT scanners (paper 
2.1). This really open a new windows of opportunities for using CCT in CHD, especially when 
CMR requires long sedation times and a high spatial resolution is considered useful for 
treatment planning. 
Conversely, CMR holds a pivotal role when functional and flow imaging is required. We 
showed the role of CMR in evaluating of patients percutaneously implanted with a pulmonary 
valve (papers 3.1 and 3.4). Moreover, we proposed two new approaches for post-processing 
CMR images, regarding volume estimation of patients with a single ventricle, a rare CHD 
(papers 3.2 and 3.5) and a method for quantifying the paradoxical septal motion (paper 3.3), a 
typical consequence of alteration of right heart function that can happen in CHD. 
In conclusion CMR and CCT are two fundamental imaging techniques to evaluate patients 
with complex CHD. In the last years, we are moving from a competition to cooperation 
between CCT and CMR. Both imaging modalities have limitations and advantages. CMR can 
evaluate heart function vessel flow but require a long acquisition time and in same patients a 
long sedation time. CCT has a very high spatial resolution and short acquisition time but 
implies ionizing radiation exposure. On the one side, we confirming the crucial role of CMR 
when function analysis is required but also showed the relevant possibilities of x-ray dose 
reduction in CCT, also using standard 64-slice scanners in the study of CHD patients.  
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